HIV immunization programmes will only be effective if sufficient numbers of
persons accept the vaccine. Our aims were to evaluate HIV vaccine acceptab
ility among adolescents and to examine how vaccine characteristics influenc
e acceptability. We recruited 661 adolescents from community health clinics
in Indianapolis, Indiana, USA to complete either written or computerized q
uestionnaires, both of which assessed HIV vaccine acceptability as a functi
on of efficacy, cost, type of vaccine, mode of delivery, and parental permi
ssion for immunization (required or not required).
For both the written and computer methods, efficacy had the strongest effec
t on acceptability, followed by type of vaccine and cost. Low efficacy, hig
h cost, and live-attenuated vaccines were associated with lower acceptabili
ty.
These findings suggest that as efforts to develop HIV vaccines continue, it
will be important, in parallel, to anticipate potential obstacles to vacci
ne acceptance, including the belief that a less efficacious HIV vaccine is
unacceptable.